Choline and Fructooligosaccharide: Non-alcoholic Fatty Liver Disease, Cardiac Fat Deposition, and Oxidative Stress Markers.

Autor: Borges Haubert NJ; Division of Medical Nutrition (Nutrology), São Paulo University, São Paulo, Brazil., Marchini JS; Division of Medical Nutrition (Nutrology), São Paulo University, São Paulo, Brazil., Carvalho Cunha SF; Division of Medical Nutrition (Nutrology), São Paulo University, São Paulo, Brazil., Suen VM; Division of Medical Nutrition (Nutrology), São Paulo University, São Paulo, Brazil., Padovan GJ; Division of Medical Nutrition (Nutrology), São Paulo University, São Paulo, Brazil., Jordao AA Junior; Division of Nutrition and Metabolism, Department of Internal Medicine, Ribeirão Preto School of Medicine, São Paulo University, São Paulo, Brazil., Marchini Alves CM; Division of Medical Nutrition (Nutrology), São Paulo University, São Paulo, Brazil., Marchini JF; Division of Medical Nutrition (Nutrology), São Paulo University, São Paulo, Brazil., Vannucchi H; Division of Medical Nutrition (Nutrology), São Paulo University, São Paulo, Brazil.
Jazyk: angličtina
Zdroj: Nutrition and metabolic insights [Nutr Metab Insights] 2015 May 04; Vol. 8, pp. 1-6. Date of Electronic Publication: 2015 May 04 (Print Publication: 2015).
DOI: 10.4137/NMI.S24385
Abstrakt: This study investigates the treatment of non-alcoholic fatty liver disease (NAFLD) in rats with choline and fructooligosaccharide (FOS). The healthy control group received standard diet. The other three groups consisted of animals with NAFLD. Group Estr received standard diet; group Echo received standard diet plus choline (3 g/100 g diet); and group Efos received standard diet plus FOS (10 g/100 g diet). Food intake, weight, urinary nitrogen, urinary ammonia, total cholesterol, serum triacylglyceride, liver and heart weights, tissue nitrogen, tissue fat, vitamin E, TBARS, and reduced glutathione (GSH) were measured in hepatic and heart tissue. Choline and FOS treatments resulted in total mean fat reduction in liver and heart tissue of 0.2 and 1.7 g, respectively. Both treatments were equally effective in reducing hepatic and cardiac steatosis. There were no differences in the TBARS level among experimental and control groups, indicating that the proposed treatments had no added protection against free radicals. While all experimental groups had increased vitamin E and GSH levels, choline treatment led to a significant increase compared to control.
Databáze: MEDLINE